Creative Medical Technology Holdings CELZ
NASDAQ CELZ
$0.77 +0.03 (+4.05%)
At close: Oct 22, 2026 · 4:00 PM EDT

Creative Medical Technology Holdings (CELZ) Receivables - Other (2021)

Updated

Creative Medical Technology Holdings (CELZ) reported Receivables - Other of $200,000 for Q3 2021.

Analysis

Creative Medical Technology Holdings (CELZ) Receivables - Other (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 Creative Medical Technology Holdings 1.02 Mn -25.97 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 200,000.00
API Access

Creative Medical Technology Holdings Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=CELZ&period=max&api_key=YOUR_API_KEY